The PE Ratio as of November 2024 (TTM) for Disc Medicine, Inc. (IRON) is -16.45

According to Disc Medicine, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -16.45. This represents a change of 38.71% compared to the average of -11.86 of the last 4 quarters.

Disc Medicine, Inc. (IRON) Historical PE Ratio (quarterly & annually)

How has IRON PE Ratio performed in the past?

The mean historical PE Ratio of Disc Medicine, Inc. over the last ten years is -7.51. The current -16.45 PE Ratio has changed 21.80% with respect to the historical average. Over the past ten years (40 quarters), IRON's PE Ratio was at its highest in in the December 2020 quarter at 13.56. The PE Ratio was at its lowest in in the September 2023 quarter at -20.22.

Disc Medicine, Inc. (IRON) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Disc Medicine, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Disc Medicine, Inc. (IRON) Average PE Ratio

How has IRON PE Ratio performed in the past?

The current PE Ratio of Disc Medicine, Inc. (IRON) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Disc Medicine, Inc. (IRON) PE Ratio vs. Peers

How is IRON’s PE Ratio compared to its peers?

Disc Medicine, Inc.’s PE Ratio is less than Anebulo Pharmaceuticals, Inc. (-4.78), less than Adagene Inc. (-3.02), less than Acrivon Therapeutics, Inc. Common Stock (-3.24), less than AnaptysBio, Inc. (-3.88), less than Mineralys Therapeutics, Inc. (-4.06), less than Olema Pharmaceuticals, Inc. (-4.10), less than Larimar Therapeutics, Inc. (-6.07), greater than Fennec Pharmaceuticals Inc. (-120.74), less than Orchestra BioMed Holdings, Inc. (-3.76), less than Biomea Fusion, Inc. (-1.62), less than Structure Therapeutics Inc. (-14.91), greater than DICE Therapeutics, Inc. (-22.94), less than Morphic Holding, Inc. (-15.88), less than Terns Pharmaceuticals, Inc. (-5.12), less than Day One Biopharmaceuticals, Inc. (-15.73), less than Acumen Pharmaceuticals, Inc. (-1.74), less than Amylyx Pharmaceuticals, Inc. (-1.38), greater than MoonLake Immunotherapeutics (-42.02), less than Crinetics Pharmaceuticals, Inc. (-16.16), less than Centessa Pharmaceuticals plc (-12.26), less than Entrada Therapeutics, Inc. (13.90),

Build a custom stock screener for Disc Medicine, Inc. (IRON) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Disc Medicine, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Disc Medicine, Inc. (IRON) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Disc Medicine, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.